VCP
BMY icon

Verus Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Verus Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
17,858
+1,016
+6% +$58.3K 0.06% 195
2026
Q1 		$1.02M Buy
16,842
+31
+0.2% +$1.81K 0.07% 169
2025
Q4 		$907K Buy
16,811
+7,213
+75% +$347K 0.06% 177
2025
Q3 		$433K Sell
9,598
-212
-2% -$9.9K 0.03% 258
2025
Q2 		$454K Buy
9,810
+3,389
+53% +$166K 0.04% 227
2025
Q1 		$392K Buy
6,421
+278
+5% +$16.2K 0.04% 240
2024
Q4 		$347K Sell
6,143
-188
-3% -$10.5K 0.03% 257
2024
Q3 		$328K Sell
6,331
-114
-2% -$5.35K 0.03% 252
2024
Q2 		$268K Sell
6,445
-1,147
-15% -$51.3K 0.03% 278
2024
Q1 		$412K Buy
7,592
+861
+13% +$43.9K 0.05% 220
2023
Q4 		$345K Buy
6,731
+553
+9% +$29K 0.04% 217
2023
Q3 		$359K Sell
6,178
-389
-6% -$23.8K 0.05% 203
2023
Q2 		$420K Sell
6,567
-320
-5% -$21.5K 0.06% 182
2023
Q1 		$477K Sell
6,887
-15
-0.2% -$1.06K 0.07% 158
2022
Q4 		$497K Sell
6,902
-36
-0.5% -$2.71K 0.09% 147
2022
Q3 		$493K Sell
6,938
-135
-2% -$9.79K 0.09% 147
2022
Q2 		$639K Sell
7,073
-1,346
-16% -$103K 0.13% 123
2022
Q1 		$645K Buy
+8,419
New +$565K 0.1% 142
2020
Q1 		$875K Buy
15,690
+1,046
+7% +$63.9K 0.27% 56
2019
Q4 		$940K Buy
+14,644
New +$839K 0.31% 58

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Verus Capital Partners's BMY Position: Q2 2026 in Review

Verus Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2026, buying an estimated $58.3K and bringing the position to 17,858 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #195.

Verus Capital Partners first reported a position in BMY in Q4 2019 and has held it in 20 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Verus Capital Partners held 17,858 shares of Bristol-Myers Squibb worth $1.03M as of Q2 2026.
  • Verus Capital Partners bought 1,016 Bristol-Myers Squibb shares in Q2 2026, an estimated $58.3K.
  • Bristol-Myers Squibb made up 0.06% of Verus Capital Partners's portfolio in Q2 2026, its #195 holding.
  • Verus Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 20 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Verus Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.